{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:15:29Z","timestamp":1790417729481,"version":"4.1.0"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Refractory celiac disease (RCD) and enteropathy-associated T-cell lymphoma (EATL) are rare, yet severe complications of celiac disease (CD). Over the last decades, several studies have addressed the biology and clinical-pathological features of such conditions, highlighting unique disease patterns and recurrent genetic events. Current classification proposals identify two forms of RCD, namely: (i) type 1 RCD (RCD-I), characterized by phenotypically normal intra-epithelial lymphocytes (IELs); and (ii) type 2 RCD (RCD-II), featuring phenotypically aberrant IELs. While RCD-I likely represents a gluten-independent dysimmune reaction against small bowel epithelial cells, RCD-II is better considered an <jats:italic>in situ<\/jats:italic> aggressive T-cell lymphoma, with high rates of progression to overt EATL. The diagnosis of RCD and EATL is often challenging, due to misleading clinical-pathological features and to significant overlap with several CD-unrelated gastro-intestinal disorders. Similarly, the treatment of RCD and EATL is an unmet clinical need for both gastroenterologists and hematologists. Moving from such premises, this review aims to provide a comprehensive view of RCD and EATL, specifically considering their pathogenesis and the many still open issues concerning their diagnosis and clinical management.<\/jats:p>","DOI":"10.3389\/fonc.2023.1273305","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:54:07Z","timestamp":1699347247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges"],"prefix":"10.3389","volume":"13","author":[{"given":"Federico","family":"Scarmozzino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pelizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Angerilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Paolo","family":"Dei Tos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Zingone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-157","article-title":"Celiac disease: histology-differential diagnosis-complications: A Pract approach","volume":"112","author":"Villanacci","year":"2020","journal-title":"Pathologica."},{"key":"B2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1423-0127-19-88","article-title":"HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing","volume":"19","author":"Megiorni","year":"2012","journal-title":"J BioMed Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: a comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.3390\/cancers13215288","article-title":"The risk of Malignancies in celiac disease\u2014A literature review","volume":"13","author":"Pelizzaro","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.06.023","article-title":"Guidelines of the Italian societies of gastroenterology on the diagnosis and management of coeliac disease and dermatitis herpetiformis","volume":"54","author":"Zingone","year":"2022","journal-title":"Digestive Liver Disease."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.1.111","article-title":"Grains of truth: evolutionary changes in small intestinal mucosa in response to environmental antigen challenge","volume":"31","author":"Marsh","year":"1990","journal-title":"Gut."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.023978","article-title":"Coeliac disease","volume":"58","author":"Corazza","year":"2005","journal-title":"J Clin Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.03.019","article-title":"Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease","volume":"5","author":"Corazza","year":"2007","journal-title":"Clin Gastroenterol Hepatology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.3390\/nu13113993","article-title":"The gluten-free diet for celiac disease and beyond","volume":"13","author":"Aljada","year":"2021","journal-title":"Nutrients."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05917.x","article-title":"Etiology of nonresponsive celiac disease: results of a systematic approach","volume":"97","author":"Abdulkarim","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.12.006","article-title":"Etiologies and predictors of diagnosis in nonresponsive celiac disease","volume":"5","author":"Leffler","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000392","article-title":"Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet","volume":"50","author":"Stasi","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07284.x","article-title":"Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease","volume":"98","author":"Vahedi","year":"2003","journal-title":"Am J Gastroenterology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11894-020-0756-8","article-title":"Refractory celiac disease","volume":"22","author":"Hujoel","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut."},{"key":"B19","first-page":"A5307","article-title":"Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review","volume":"63","author":"Rowinski","year":"2016","journal-title":"Dan Med J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.08.022","article-title":"Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade","volume":"55","author":"Elli","year":"2023","journal-title":"Digestive Liver Disease."},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13867","article-title":"Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years","volume":"45","author":"Eigner","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12606","article-title":"Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease","volume":"39","author":"Ilus","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0595-1","article-title":"Complications in celiac disease under gluten-free diet","volume":"54","author":"Tursi","year":"2009","journal-title":"Dig Dis Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","article-title":"Clinical staging and survival in refractory celiac disease: a single center experience","volume":"136","author":"Rubio\u2013Tapia","year":"2009","journal-title":"Gastroenterology."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2018.09.010","article-title":"Refractory celiac disease","volume":"48","author":"Malamut","year":"2019","journal-title":"Gastroenterol Clin North Am"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Rubio-Tapia","year":"2010","journal-title":"Gut."},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.15403\/jgld.2014.1121.281.cel","article-title":"Capsule endoscopy in the management of refractory coeliac disease","volume":"28","author":"Zammit","year":"2019","journal-title":"J Gastrointestinal Liver Diseases."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13755","article-title":"Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry","volume":"44","author":"Rubio-Tapia","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.3390\/cancers13102289","article-title":"Serum markers of refractoriness and enteropathy-associated T-cell lymphoma in coeliac disease","volume":"13","author":"Lenti","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.426","article-title":"Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease","volume":"109","author":"Di Sabatino","year":"2014","journal-title":"Am J Gastroenterology."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.07.086","article-title":"AGA clinical practice update on management of refractory celiac disease: expert review","volume":"163","author":"Green","year":"2022","journal-title":"Gastroenterology."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.439","article-title":"Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients","volume":"111","author":"Comino","year":"2016","journal-title":"Am J Gastroenterology."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310148","article-title":"Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing","volume":"66","author":"Moreno M de","year":"2017","journal-title":"Gut."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07379.x","article-title":"High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal","volume":"98","author":"Tursi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181557e67","article-title":"Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease","volume":"43","author":"Rubio-Tapia","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/a-1973-3796","article-title":"Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline \u2013 Update 2022","volume":"55","author":"Pennazio","year":"2023","journal-title":"Endoscopy."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-016-1032-0","article-title":"Cross-sectional imaging in refractory celiac disease","volume":"42","author":"Al-Bawardy","year":"2017","journal-title":"Abdominal Radiology."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/2050640616663571","article-title":"Splenic volume differentiates complicated and non-complicated celiac disease","volume":"5","author":"Gils","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","volume":"112","author":"Mukewar","year":"2017","journal-title":"Am J Gastroenterology."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01380.x","article-title":"Budesonide in the treatment of refractory celiac disease","volume":"102","author":"Brar","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T cells","volume":"4","author":"Al\u2013toma","year":"2006","journal-title":"Clin Gastroenterol Hepatology."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.089987","article-title":"A severe but reversible refractory sprue","volume":"55","author":"Dray","year":"2005","journal-title":"Gut."},{"key":"B44","doi-asserted-by":"publisher","first-page":"bcr2015209363","DOI":"10.1136\/bcr-2015-209363","article-title":"A 37-year-old woman with refractory coeliac disease type II disease treated by stem cell transplantation","volume":"24","author":"Maheshwari","year":"2015","journal-title":"BMJ Case Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.199","article-title":"Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy","volume":"46","author":"Tack","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells","volume":"109","author":"Al-toma","year":"2007","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience","volume":"56","author":"Al-toma","year":"2007","journal-title":"Gut."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia [Internet]."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.3.333","article-title":"Malignancy in coeliac disease\u2013effect of a gluten free diet","volume":"30","author":"Holmes","year":"1989","journal-title":"Gut."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2541","article-title":"Genome\u2013virome interactions: examining the role of common viral infections in complex disease","volume":"9","author":"Foxman","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.12.011","article-title":"Human leukocyte antigen\u2013DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma","volume":"4","author":"Al\u2013Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatology."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.08.018","article-title":"The MYO9B gene is a strong risk factor for developing refractory celiac disease","volume":"5","author":"Wolters","year":"2007","journal-title":"Clin Gastroenterol Hepatology."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001168","article-title":"A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease","volume":"30","author":"Hrdlickova","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.005","article-title":"Development, differentiation, and diversity of innate lymphoid cells","volume":"41","author":"Diefenbach","year":"2014","journal-title":"Immunity."},{"key":"B57","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2022","journal-title":"Gut."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01594.x","article-title":"Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease","volume":"125","author":"O\u2019Keeffe","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620036114","article-title":"CD4 T-cell cytokines synergize to induce proliferation of Malignant and nonmalignant innate intraepithelial lymphocytes","volume":"114","author":"Kooy-Winkelaar","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12690","article-title":"High Smad7 sustains inflammatory cytokine response in refractory coeliac disease","volume":"150","author":"Sedda","year":"2017","journal-title":"Immunology."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317371","article-title":"NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study","volume":"68","author":"Cheminant","year":"2019","journal-title":"Gut."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205023","article-title":"Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease","volume":"71","author":"Hussein","year":"2018","journal-title":"J Clin Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326645","article-title":"Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus","volume":"71","author":"Schiepatti","year":"2022","journal-title":"Gut."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.12.044","article-title":"Features of adult autoimmune enteropathy compared with refractory celiac disease","volume":"16","author":"Sharma","year":"2018","journal-title":"Clin Gastroenterol Hepatology."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.013","article-title":"Adult autoimmune enteropathy: mayo clinic rochester experience","volume":"5","author":"Akram","year":"2007","journal-title":"Clin Gastroenterol Hepatology."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1159\/000370205","article-title":"Drug-induced enteropathy","volume":"33","author":"Marietta","year":"2015","journal-title":"Digestive Diseases."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02855","article-title":"Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus","volume":"63","author":"Padwal","year":"2014","journal-title":"Hypertension."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.003","article-title":"Severe spruelike enteropathy associated with olmesartan","volume":"87","author":"Rubio-Tapia","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12937","article-title":"Olmesartan-associated enteropathy: results of a national survey","volume":"40","author":"Marthey","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"B71","doi-asserted-by":"publisher","first-page":"S302","DOI":"10.14309\/00000434-201310001-01011","article-title":"Severe enteropathy in a patient on valsartan","volume":"108","author":"Herman","year":"2013","journal-title":"Am J Gastroenterology."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2004.tb00471.x","article-title":"Villous atrophy induced by mycophenolate mofetil in renal-transplant patients","volume":"17","author":"Kamar","year":"2004","journal-title":"Transplant Int"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.6750","article-title":"Management of immune-related adverse events and kinetics of response with ipilimumab","volume":"30","author":"Weber","year":"2012","journal-title":"J Clin Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.45","article-title":"Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma","volume":"108","author":"DeGaetani","year":"2013","journal-title":"Am J Gastroenterology."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterology."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.06.022","article-title":"Excess IL-12 but not IL-23 Accompanies the Inflammatory Bowel Disease Associated With Common Variable Immunodeficiency","volume":"131","author":"Mannon","year":"2006","journal-title":"Gastroenterology."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07159.x","article-title":"Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients","volume":"98","author":"Luzi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"B78","first-page":"1","article-title":"Primary immunodeficiency diseases. Report of a WHO scientific group","author":"Rosen","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"B79","first-page":"391","article-title":"Tropical sprue in 2014: the new face of an old disease","volume-title":"Curr Gastroenterol Rep","author":"Ghoshal","year":"2014"},{"key":"B80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jgh.14403","article-title":"Clinical, endoscopic, and histological differentiation between celiac disease and tropical sprue: a systematic review","volume":"34","author":"Sharma","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1177\/1066896920947795","article-title":"Giardia is often overlooked on histopathologic examination: a high-volume, single-institution experience","volume":"29","author":"Shen","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.cgh.2013.05.031","article-title":"Collagenous sprue, an enigma in the spectrum of celiac disease","volume":"12","author":"Jain","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/PAP.0000000000000311","article-title":"Upper gastrointestinal tract involvement in inflammatory bowel diseases: histologic clues and pitfalls","volume":"29","author":"K\u0151v\u00e1ri","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPBKQND4SHVX9Q","article-title":"Normal villous architecture with increased intraepithelial lymphocytes","volume":"143","author":"Patterson","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1177\/1066896921998438","article-title":"Histopathologic manifestations of crohn disease in duodenal endoscopy biopsy: the value of different patterns of involvement of brunner glands","volume":"29","author":"AbdullGaffar","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2018.08.006","article-title":"A single-tube, euroClonality-inspired, TRG clonality multiplex PCR aids management of patients with enteropathic diseases, including from formaldehyde-fixed, paraffin-embedded tissues","volume":"21","author":"Derrieux","year":"2019","journal-title":"J Mol Diagnostics."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0075-7","article-title":"Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease","volume":"34","author":"van Wanrooij","year":"2014","journal-title":"J Clin Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hon.2720","article-title":"Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system","volume":"38","author":"Soderquist","year":"2020","journal-title":"Hematol Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.01.014","article-title":"Origin and immunophenotype of aberrant IEL in RCDII patients","volume":"50","author":"Tack","year":"2012","journal-title":"Mol Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","article-title":"Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease","volume":"126","author":"Verbeek","year":"2008","journal-title":"Clin Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20481","article-title":"Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization","author":"Verbeek","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.205","article-title":"Refractory coeliac sprue is a diffuse gastrointestinal disease","volume":"52","author":"Verkarre","year":"2003","journal-title":"Gut."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Digestive Liver Disease."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.3.372","article-title":"Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression","volume":"51","author":"Farstad","year":"2002","journal-title":"Gut."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"deLeeuw","year":"2007","journal-title":"Gastroenterology."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26700","article-title":"Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008","volume":"118","author":"Sharaiha","year":"2012","journal-title":"Cancer."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802240222","article-title":"Incidence of enteropathy - associated T-cell lymphoma: A nation-wide study of a population-based registry in The Netherlands","volume":"43","author":"Verbeek","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.02.027","article-title":"Association of celiac disease and intestinal lymphomas and other cancers","volume":"128","author":"Catassi","year":"2005","journal-title":"Gastroenterology."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2015.04.014","article-title":"Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis","volume":"35","author":"Wierdsma","year":"2016","journal-title":"Clin Nutr"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199509000-00012","article-title":"Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era","volume":"21","author":"Egan","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2195","article-title":"A new and validated clinical prognostic model (EPI) for enteropathy-associated T-cell lymphoma","volume":"21","author":"de Baaij","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0021","article-title":"Brentuximab in the treatment of CD30-positive enteropathy-associated T-cell lymphoma","volume":"11","author":"Khalaf","year":"2013","journal-title":"J Natl Compr Cancer Network."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003218","article-title":"Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy","volume":"4","author":"Voorhees","year":"2020","journal-title":"Blood Adv"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/path.1703","article-title":"Gastrointestinal lymphoma: where morphology meets molecular biology","volume":"205","author":"Isaacson","year":"2005","journal-title":"J Pathol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150748","article-title":"Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor\u2013CD3 expression in enteropathy-associated T-cell lymphoma","volume":"112","author":"Tjon","year":"2008","journal-title":"Blood."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ Intestinal lymphomas are CD8+CD5\u2013 T-cell lymphomas of monomorphic small to medium size histology","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1647455","article-title":"Two cases of monomorphic epitheliotropic intestinal T-cell lymphoma associated with coeliac disease","volume":"54","author":"Lenti","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairism\u00e4gi","year":"2016","journal-title":"Leukemia."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.178","article-title":"Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas","volume":"30","author":"Nicolae","year":"2016","journal-title":"Leukemia."},{"key":"B116","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1273305\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:54:11Z","timestamp":1699347251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1273305\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":116,"alternative-id":["10.3389\/fonc.2023.1273305"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1273305","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"article-number":"1273305"}}